InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Discover the detailed record of transactions filed by Privitera Salvatore, Chief Technology Officer. Director active across 1 companies, notably AtriCure, Inc.. Cumulatively, 11 filings have been recorded. Total volume traded: €2.6m. The latest transaction was disclosed on 1 March 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations11 total
07,789 shares0
Common Stock
SEC:0001323885-22-000022:0·
€7,880151 shares@ €52.18530.0006% mcap0.6% of flow
Common Stock
SEC:0001209191-22-000390·
€7,880151 shares@ €52.18530.0006% mcap0.3% of flow
Common Stock
SEC:0001209191-22-000390:0·
€629,5138,808 shares@ €71.47060.044% mcap47.1% of flow
Common Stock
SEC:0001209191-21-049167·
€629,5138,808 shares@ €71.47060.044% mcap23.5% of flow
Common Stock
SEC:0001209191-21-049167:0·
€557,1528,000 shares@ €69.6440.039% mcap41.7% of flow
Common Stock
SEC:0001209191-21-048737·
€557,1528,000 shares@ €69.6440.039% mcap20.8% of flow
Common Stock
SEC:0001209191-21-048737:0·
€135,7762,000 shares@ €67.8880.0095% mcap10.2% of flow
Common Stock
SEC:0001209191-21-047752·
€135,7762,000 shares@ €67.8880.0095% mcap5.1% of flow
Common Stock
SEC:0001209191-21-047752:0·
€6,594171 shares@ €38.56020.0005% mcap0.5% of flow
Common Stock
SEC:0001209191-21-044923·
€6,594171 shares@ €38.56020.0005% mcap0.2% of flow
Common Stock
SEC:0001209191-21-044923:0·
11 of 11 declarations
About Privitera Salvatore
Salvatore Privitera is the Chief Technical Officer of AtriCure, Inc. In this role, he is responsible for the technical direction and innovation within the company. Privitera plays a key role in developing new technologies and medical solutions, contributing to improving AtriCure's products and services. His technical expertise is essential to support the company's mission.
